Clinical trials
Biliary Atresia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 2 |
| 2013 | 2 |
| 2016 | 3 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 7 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arbor Research Collaborative for Health | 3 |
| Albireo, an Ipsen Company | 2 |
| Baylor College of Medicine | 2 |
| Children's Hospital Medical Center, Cincinnati | 2 |
| Holterman, Ai-Xuan, M.D. | 2 |
| Mirum Pharmaceuticals, Inc. | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Boston Children's Hospital | 1 |
| National Center for Research Resources (NCRR) | 1 |
| Sacramento Pediatric Gastroenterology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Atresia | 22 |
| Cholestasis | 4 |
| Alagille Syndrome | 3 |
| Cholangitis, Sclerosing | 2 |
| Rare Diseases | 2 |
| Addison Disease | 1 |
| Alstrom Syndrome | 1 |
| Amnesia, Transient Global | 1 |
| Aniridia | 1 |
| Ataxia | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.